GSK plc (GSK) Form 6-K — Sep 11, 2026
GSK plc filed a Form 6-K on September 11, 2026 containing routine transaction notifications for persons discharging managerial responsibilities (PDMRs) under UK market abuse disclosure rules. Nine senior executives, including CFO Julie Brown, President Europe Lynn Baxter, General Counsel James Ford, and ViiV Healthcare CEO Deborah Waterhouse, each acquired 14 ordinary shares at £18.0296 per share under GSK's Share Reward Plan on September 9, 2026, with the trades executed on the London Stock Exchange.
Key figures
- Isin
- GB00BN7SWP63
- Instrument
- Ordinary shares of 31 1/4 pence each
- Transaction Date
- 2026-09-09
- Price Per Share GBP
- £18.0296
- Share Composition
- 7 partnership shares + 7 matching shares per notification
- Transaction Venue
- London Stock Exchange (XLON)
- Number Of Notifications
- 9
- Shares Per Notification
- 14
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.